Subthalamic Steering for Therapy Optimization in Parkinson's Disease
NCT: NCT03548506 · COMPLETED
Brief Summary
Twenty patients with idiopathic Parkinson's disease (PD) will be included into this single center randomized controlled double-blind clinical trial (RCT) in a cross-over design. The treatment consists of two different stimulation settings using (i) conventional omnidirectional stimulation of the subthalamic nucleus \[STN\_O\] as active comparator and (ii) directional steering of STN stimulation via a segmented electrode contact \[STN\_D\].
Frequently Asked Questions
What is Subthalamic Steering for Therapy Optimization in Parkinson's Disease?
Subthalamic Steering for Therapy Optimization in Parkinson's Disease is a clinical trial registered under NCT03548506. Current status: COMPLETED.
What is the status of NCT03548506?
The current status of NCT03548506 (Subthalamic Steering for Therapy Optimization in Parkinson's Disease) is: COMPLETED.
When did Subthalamic Steering for Therapy Optimization in Parkinson's Disease start?
Subthalamic Steering for Therapy Optimization in Parkinson's Disease started on 2018-04-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.